Cours DanDrit Biotech USA Inc OTC Bulletin Board
Actions
US2360781015
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2022 | - | CA 2023 | - | Capitalisation | 34,41 M 31,32 M |
---|---|---|---|---|---|
Résultat net 2022 | -113 M -103 M | Résultat net 2023 | -39 M -35,5 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 1,99 M 1,81 M | Dette nette 2023 | 3,9 M 3,55 M | VE / CA 2023 | - |
PER 2022 |
-0,89
x | PER 2023 |
-0,8
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 73,77% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 23/01/18 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 21/08/23 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 01/01/20 |
Avram Miller
BRD | Director/Board Member | - | 11/10/23 |
James Sapirstein
BRD | Director/Board Member | 63 | 06/03/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,65% | 104 Md | |
+6,75% | 97,47 Md | |
+5,71% | 22,25 Md | |
-12,60% | 21,68 Md | |
-9,70% | 18,2 Md | |
-39,98% | 17,02 Md | |
-10,17% | 16,36 Md | |
+6,12% | 14,39 Md | |
+35,47% | 12,37 Md |
- Bourse
- Actions
- Action RENB
- Action